In short
Getting a proper diagnosis when fibrosarcoma is suspected involves several steps that help doctors identify this rare cancer and plan the best treatment approach. Understanding when to seek medical attention and what tests may be needed can help patients feel more prepared during this process.
Key points
- Any persistent, painless lump that continues to grow deserves medical attention, even though most lumps turn out to be harmless
- Fibrosarcoma often hides deep in soft tissues, so symptoms may not appear until the tumor grows large enough to press on nerves or blood vessels
- A biopsy is the only way to definitively diagnose fibrosarcoma—imaging tests alone cannot confirm the diagnosis
- The biopsy should be carefully planned and reviewed by a pathologist experienced in sarcomas to ensure accurate diagnosis and not compromise future treatment
- Infantile fibrosarcoma often has a specific genetic signature involving NTRK genes, which can be important for treatment decisions and clinical trial eligibility
- Multiple imaging tests serve different purposes: MRI shows soft tissue detail, CT checks for lung spread, and x-rays reveal bone involvement
- Prognosis depends heavily on age, tumor grade, size, location, and whether complete surgical removal is possible
- Infantile fibrosarcoma has a much better outlook than adult-type fibrosarcoma, with three-year event-free survival rates of 84%
Introduction: Who Should Undergo Diagnostics
If you notice a painless lump or swelling in your arm, leg, or trunk that persists without an obvious cause, it's worth getting checked by a healthcare provider. This is especially important if the lump continues to grow over time. While many lumps are harmless, fibrosarcoma often begins as a soft tissue mass that may not cause discomfort at first.
Because fibrosarcoma develops deep within soft tissues, symptoms might not appear until the tumor grows large enough to press on nearby nerves or blood vessels. When this happens, you might experience tingling sensations, a "pins and needles" feeling, or even sharp, aching, or burning pain. Unusual swelling in a limb could also signal that the tumor is affecting blood flow.
Parents should seek medical evaluation if their infant or young child develops a rapidly growing mass at birth or shortly after. Infantile fibrosarcoma, while generally less aggressive than the adult type, still requires prompt diagnosis and treatment. In older children and adolescents, any persistent lump or swelling should be examined, as the adult form of fibrosarcoma can occur in this age group as well.
Adults between the ages of 20 and 60 are most commonly affected by adult-type fibrosarcoma, though anyone can develop this condition. If you fall into a higher-risk category—such as having received radiation therapy in the past, having chronic lymphedema, or having certain inherited conditions like Li-Fraumeni syndrome or neurofibromatosis type 1—you should be particularly vigilant about any new lumps or masses.
Classic Diagnostic Methods
When you visit a healthcare provider with concerns about a possible fibrosarcoma, the diagnostic process typically begins with a thorough physical examination. Your doctor will look at and feel any lumps or swelling, asking questions about when you first noticed the changes, whether the lump has grown, and if you're experiencing any pain or other symptoms.
Imaging Studies
After the physical exam, your doctor will likely order imaging tests to get a detailed look at the suspicious area. These pictures help doctors see the size, location, and extent of any tumor. Several different imaging techniques may be used, depending on where the lump is located and what information the doctor needs.
X-rays are often the first imaging test performed. These simple radiographs can show if a tumor is affecting bone tissue. While x-rays provide basic information, they may not give enough detail about soft tissue masses, so additional imaging is usually needed.
Magnetic resonance imaging (MRI) is particularly useful for examining soft tissue tumors like fibrosarcoma. This test uses powerful magnets and radio waves to create detailed images of muscles, tendons, ligaments, and other connective tissues. An MRI can show exactly where the tumor is located, how big it is, and whether it's affecting nearby structures. This information helps doctors plan the best approach for biopsy and treatment.
Computed tomography (CT) scans combine multiple x-ray images taken from different angles to create cross-sectional views of the body. CT scans are especially helpful for checking whether fibrosarcoma has spread to other areas, particularly the lungs. Since soft tissue sarcomas can sometimes spread to the chest, a CT scan of this area is often part of the diagnostic workup.
Ultrasound uses sound waves to create images of soft tissues. This test can help distinguish between solid masses and fluid-filled cysts. In some cases, ultrasound may be used to guide a biopsy needle to the exact location of the tumor.
Positron emission tomography (PET) scans and bone scans may be used along with other imaging tests. PET scans are particularly useful for certain types of sarcomas that have a tendency to spread to lymph nodes, such as synovial sarcoma and epithelioid sarcoma. These tests can help doctors see if the cancer has spread to areas that might not show up clearly on other imaging studies.
Biopsy
While imaging tests can show that a tumor is present, only a biopsy can definitively diagnose fibrosarcoma. A biopsy involves removing a small sample of the tumor so it can be examined under a microscope by a pathologist. This specialist looks at the cells to determine whether they are cancerous and, if so, what type of cancer is present.
The biopsy can be performed in different ways. An image-guided core-needle biopsy uses imaging techniques like ultrasound or CT to guide a needle into the tumor to remove tissue samples. This approach is less invasive and is often the first choice when possible. For some cases, particularly when a core-needle biopsy cannot be safely performed or when previous attempts were not successful, doctors may perform an incisional biopsy. This involves making a small surgical cut to remove a piece of the tumor.
The biopsy procedure for children is typically done under general anesthesia, meaning the child is asleep and won't feel any pain. The sample or pieces of the tumor are then examined under a microscope to confirm the diagnosis.
Blood Tests
Your doctor may also order blood tests as part of the diagnostic process. A complete blood count (CBC) checks the levels of different blood cells, while other blood tests can assess your overall health and how well your organs are functioning. These tests don't diagnose fibrosarcoma directly, but they provide important baseline information that helps guide treatment planning.
Determining Disease Spread
Once fibrosarcoma is diagnosed, additional tests may be performed to see if the cancer has spread beyond its original location. This process is called staging. For fibrosarcoma, doctors particularly look for spread to the lungs, as this is the most common site for metastases. CT scans of the chest are commonly used for this purpose.
In some cases, doctors may also check for spread to bone marrow by performing a bone marrow aspirate. Radioisotope scans can show if the cancer has affected bones in other parts of the body. These tests help doctors understand how far the cancer may have spread, which is crucial for determining the stage of the cancer and planning the most appropriate treatment.
Diagnostics for Clinical Trial Qualification
When patients are being considered for enrollment in clinical trials, they typically undergo a standardized set of diagnostic tests. These tests serve multiple purposes: they confirm the diagnosis, determine the extent of the disease, and establish baseline measurements that will be used to track how well the experimental treatment works.
Clinical trials testing new treatments for fibrosarcoma usually require comprehensive staging evaluations before patients can participate. This includes imaging studies such as CT scans and MRI to assess the extent of the primary tumor and check for metastases. Biopsies are essential not only for confirming the diagnosis but also for obtaining tissue samples that can be tested for specific genetic markers or other characteristics that might predict response to treatment.
Some clinical trials, particularly those testing targeted therapies, may require genetic testing of the tumor tissue. For example, researchers have found that about 90% of infantile fibrosarcomas involve problems with the NTRK gene family. When these genes aren't working properly, tumors can form. Clinical trials testing drugs that target these specific genetic abnormalities would require this genetic information before enrolling patients.
Blood tests are typically part of the qualification process for clinical trials. These include complete blood counts to ensure that patients have adequate blood cell levels, as well as tests of kidney and liver function to make sure patients can safely tolerate the experimental treatments being studied.
Imaging tests may need to be repeated at specific intervals during the clinical trial to monitor how the tumor responds to treatment. Standardized measurements of tumor size help researchers determine whether a new treatment is effective. These follow-up scans are usually performed using the same imaging technique that was used before treatment began, to ensure accurate comparisons.
For trials involving surgical approaches, detailed imaging studies help surgeons plan the procedure and determine whether complete removal of the tumor is feasible without causing unacceptable functional loss. This is particularly important for fibrosarcomas affecting the limbs, where preserving function is a major goal.
Performance status assessments are also commonly required for clinical trial participation. These evaluations measure how well you can carry out everyday activities and help determine whether you're healthy enough to tolerate the experimental treatment being studied. Your medical team will assess factors like your ability to walk, care for yourself, and carry out normal daily activities.
Prognosis and Survival Rate
Prognosis
The outlook for patients with fibrosarcoma depends on several interconnected factors. Age plays a significant role: infantile fibrosarcoma, which occurs at birth or shortly after, typically has an excellent prognosis. This type grows quickly but rarely spreads to other parts of the body and is usually curable. In contrast, adult-type fibrosarcoma tends to be more aggressive and harder to treat.
The location and size of the tumor significantly affect prognosis. Smaller tumors that are discovered early generally have better outcomes than larger ones. The tumor's grade is also crucial—high-grade fibrosarcomas (Grade 2 or 3) are more aggressive than low-grade tumors. Studies show that about 80% of adult fibrosarcomas are classified as high-grade, and about 25% of low-grade tumors can progress to high-grade sarcomas over time.
Whether the tumor has spread is perhaps the most important factor affecting prognosis. Fibrosarcomas that remain localized, meaning they haven't spread beyond their original location, have much better outcomes than those that have metastasized to the lungs or other areas. The presence of metastatic disease significantly reduces survival chances.
The success of surgical removal also influences prognosis. If the entire tumor can be removed with clear margins (meaning no cancer cells are left at the edges of the removed tissue), the chances of cure are much higher. Complete removal is especially important for preventing the cancer from coming back in the same location.
Survival Rate
For infantile fibrosarcoma, the prognosis is generally very good. The three-year event-free survival rate has been reported at 84% in studies using conservative treatment approaches. Many infants with this type of fibrosarcoma can be cured, especially when the tumor can be completely removed or responds well to treatment.
For adult-type fibrosarcoma, survival rates vary depending on the stage and grade of the tumor. Patients with localized disease that can be completely removed have better survival rates than those with metastatic disease. With combined treatment approaches including surgery, radiation, and sometimes chemotherapy, survival rates have been improving over time.
The prognosis for children with fibrosarcoma is linked to several factors: the age of the patient (infants versus older children), where the tumor is located, whether it has spread to other parts of the body, and whether the tumor was fully removed during surgery. With modern combined treatment approaches, survival rates continue to improve.
